Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
Author
Russell, Mark D.Dey, Mrinalini
Flint, Julia
Davie, Philippa
Allen, Alexander
Crossley, Amy
Frishman, Margreta
Gayed, Mary
Hodson, Kenneth
Khamashta, Munther
Moore, Louise
Panchal, Sonia
Piper, Madeleine
Reid, Clare
Saxby, Katherine
Schreiber, Karen
Senvar, Naz
Tosounidou, Sofia
van de Venne, Maud
Warburton, Louise
Williams, David
Yee, Chee-Seng
Gordon, Caroline
Giles, Ian
BSR Standards, Audit and Guidelines Working Group
Affiliation
South Warwickshire University NHS Foundation Trust; et al.Publication date
2023-04
Metadata
Show full item recordAbstract
An Executive Summary of the British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsCitation
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023 Apr 3;62(4):1370-1387. doi: 10.1093/rheumatology/keac558.Type
GuidelineAdditional Links
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc10070067/PMID
36318965Journal
RheumatologyPublisher
Oxford University Pressae974a485f413a2113503eed53cd6c53
10.1093/rheumatology/keac558